Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Shetterly

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Pharmacoepidemiology and Drug Safety|June 23, 2018
Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney diseaseDavid H Smith, Susan Shetterly, James Flory, et al.
American Journal of Epidemiology|February 11, 2017
Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older WomenMarsha A Raebel, Chan Zeng, T Craig Cheetham, et al.
Age and Ageing|January 26, 2023
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribedEmily Reeve, Elizabeth A Bayliss, Susan Shetterly, et al.
JAMA Pediatrics|February 10, 2015
Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trialBruce G Bender, Peter J Cvietusa, Glenn K Goodrich, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2016
Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expectedMarsha A Raebel, Susan Shetterly, Christine Y Lu, et al.
Journal of Lipid Research|September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoEBrandon Ason, José W A van der Hoorn, Joyce Chan, et al.
The Journal of Clinical Investigation|November 19, 2020
The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injuryPaul F Lebeau, Hanny Wassef, Jae Hyun Byun, et al.
JAMA|July 11, 2013
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiariesDaniel D Matlock, Peter W Groeneveld, Steve Sidney, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2009
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primatesJoyce C Y Chan, Derek E Piper, Qiong Cao, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Pharmacoepidemiology and Drug Safety|June 23, 2018
Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney diseaseDavid H Smith, Susan Shetterly, James Flory, et al.
American Journal of Epidemiology|February 11, 2017
Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older WomenMarsha A Raebel, Chan Zeng, T Craig Cheetham, et al.
Age and Ageing|January 26, 2023
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribedEmily Reeve, Elizabeth A Bayliss, Susan Shetterly, et al.
JAMA Pediatrics|February 10, 2015
Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trialBruce G Bender, Peter J Cvietusa, Glenn K Goodrich, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2016
Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expectedMarsha A Raebel, Susan Shetterly, Christine Y Lu, et al.
Journal of Lipid Research|September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoEBrandon Ason, José W A van der Hoorn, Joyce Chan, et al.
The Journal of Clinical Investigation|November 19, 2020
The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injuryPaul F Lebeau, Hanny Wassef, Jae Hyun Byun, et al.
JAMA|July 11, 2013
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiariesDaniel D Matlock, Peter W Groeneveld, Steve Sidney, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2009
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primatesJoyce C Y Chan, Derek E Piper, Qiong Cao, et al.
Pageof 3